Yakult Honsha Co.,Ltd. (YKLTF)
Yakult Honsha Co.,Ltd. operates in the Beverages - Non-Alcoholic industry of the Consumer Defensive sector, headquartered in Tokyo, TY, JP. The stock last traded at $17.30, up 9.15% on the session, giving a market capitalisation of $4.98B. On trailing twelve-month figures it carries a trailing P/E of 18.20, a net margin of 9.4%. Its beta of 0.01 implies it has historically moved less than the broad market.
Yakult Honsha Co.,Ltd. operates as a multifaceted enterprise, specializing in the manufacturing and distribution of food and beverage products, alongside cosmetics, pharmaceuticals, and various other interests. The company's business activities are divided across distinct segments: regional Food and Beverages divisions encompassing Japan, the Americas, Asia and Oceania, and Europe, as well as dedicated Pharmaceuticals and 'Others' sectors. Within its food and beverage portfolio, Yakult Honsha supplies a range of items such as its well-known fermented milk drinks, juices, and noodle products, reaching consumers through both direct home delivery services and conventional retail channels. Furthermore, its pharmaceutical arm is responsible for producing medications, including the antineoplastic drug Elplat, and a selection of generic anti-cancer agents like Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Beyond these primary operations, the company also engages in the cosmetics market and notably owns the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. traces its origins back to its founding in Tokyo, Japan, in 1935, where its corporate headquarters are still situated.
Yakult Honsha Co.,Ltd. is most often compared with the following Consumer Defensive names: